Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	14523
Country	Canada

Received	2014-10-09 09:49
Peer-Review Started	2014-10-09 19:15
To Make the First Decision	2014-11-14 19:48
Return for Revision	2014-11-20 11:47
Revised	2014-11-22 01:46
Second Decision	2015-02-04 12:01
Accepted by Journal Editor-in-Chief	2015-02-05 02:46
Accepted by Company Editor-in-Chief	2015-04-02 16:16
Articles in Press	2015-04-02 16:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-24 10:33
Publish the Manuscript Online	2015-04-29 16:58

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Systematic Reviews
Article Title	Clinical relevance of intestinal peptide uptake
Manuscript Source	Invited Manuscript
All Author List	Hugh James Freeman
Funding Agency and Grant Number
Corresponding Author	Dr. Hugh James Freeman, MD, CM, FRCPC, FACP, Department of Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver V6T 1W5, Canada. hugfree@shaw.ca
Key Words	Dietary peptides; Peptide transport; Peptide transporter 1; Intestinal inflammation; Drug absorption; Bacterial peptides
Core Tip	Intestinal uptake of intact di-peptides and tri-peptides occurs by an independent epithelial transport process for protein assimilation. This carrier may also be used to absorb specific drugs and bacterial peptide products that may result in inflammatory disease.
Publish Date	2015-04-29 16:58
Citation	Freeman HJ. Clinical relevance of intestinal peptide uptake. World J Gastrointest Phar¬macol Ther 2015; 6(2): 22-27
URL	http://www.wjgnet.com/2150-5349/full/v6/i2/22.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v6.i2.22

Full Article (PDF)	WJGPT-6-22.pdf
Full Article (Word)	WJGPT-6-22.doc
Manuscript File	14523-Review.doc
Answering Reviewers	14523-Answering reviewers.pdf
Biostatistics Review Certificate	14523-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	14523-Conflict-of-interest statement.pdf
Copyright License Agreement	14523-Copyright assignment.pdf
Peer-review Report	14523-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	14523-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	14523-Scientific misconduct check.pdf
Scientific Editor Work List	14523-Scientific editor work list.pdf